title: Triple Antithrombotic Therapy in Atrial Fibrillation Patients With an Indication for Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A Case-Based Review of the Current Evidence.
authors.affiliation: From the Interventional Cardiology, Department of Medicine, Montreal Heart Institute, Université de Montréal, Montréal, QC, Canada.
authors.forename: Fabien
authors.initials: F
authors.lastname: Picard
authors.affiliation: From the Interventional Cardiology, Department of Medicine, Montreal Heart Institute, Université de Montréal, Montréal, QC, Canada.
authors.forename: Victor-Xavier
authors.initials: VX
authors.lastname: Tadros
authors.affiliation: From the Interventional Cardiology, Department of Medicine, Montreal Heart Institute, Université de Montréal, Montréal, QC, Canada. anita.asgar@umontreal.ca.
authors.forename: Anita W
authors.initials: AW
authors.lastname: Asgar
mesh_terms: D000284:Administration, Oral; D000368:Aged; D000925:Anticoagulants / Q000008:administration & dosage*; D001281:Atrial Fibrillation / Q000628:therapy*; D004359:Drug Therapy, Combination; D005260:Female; D005343:Fibrinolytic Agents / Q000008:administration & dosage*; D006801:Humans; D062645:Percutaneous Coronary Intervention / Q000379:methods*
chemical_list: D000925:Anticoagulants; D005343:Fibrinolytic Agents
keywords: antiplatelet therapy; atrial fibrillation; bleeding; percutaneous coronary intervention; triple therapy